Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting

BACKGROUND. The BALLET study was an open‐label, multicenter, expanded access study designed to allow treatment with everolimus plus exemestane in postmenopausal women with hormone receptor‐positive metastatic breast cancer progressed following prior endocrine therapy. A post hoc analysis to evaluate...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Generali, Daniele, Montemurro, Filippo, Bordonaro, Roberto, Mafodda, Antonino, Romito, Sante, Michelotti, Andrea, Piovano, Pierluigi, Ionta, Maria Teresa, Bighin, Claudia, Sartori, Donata, Frassoldati, Antonio, Cazzaniga, Marina Elena, Riccardi, Ferdinando, Testore, Franco, Vici, Patrizia, Barone, Carlo Antonio, Schirone, Alessio, Piacentini, Federico, Nolè, Franco, Molino, Annamaria, Latini, Luciano, Simoncini, Edda Lucia, Roila, Fausto, Cognetti, Francesco, Nuzzo, Francesco, Foglietta, Jennifer, Minisini, Alessandro Marco, Goffredo, Francesca, Portera, Giuseppe, Ascione, Gilda, Mariani, Gabriella
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2017
Subjects:
Breast Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5469582/
https://ncbi.nlm.nih.gov/pubmed/28432226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0461
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items